UA-Affiliated company producing early disease detection technology

June 26, 2009

By Flinn Foundation

[Source: University of Arizona Communications] – Part of the difficulty in detecting diseases like cancer early on is that the instruments available to hunt for the minute proteins indicative of a disease are not advanced enough.

The evidence is often right in the bloodstream but “blood tests are not always sensitive enough,” said Mary J. Wirth, a University of Arizona chemistry professor and chemical analyst. “The key is to develop more sensitive tools for research and clinical diagnostics.”

Detecting diseases before the onset of symptoms, she said, is one of the greatest challenges in modern-day medicine.

For more information click here.